GAULT LAURA (Chief Medical Officer) received a stock award from SAGE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/21/2025ACC: 0001562180-25-000436
Officer· Chief Medical Officer
Since Oct 2022
+24K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
24K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+24K
Price / share
—
Trade value
—
% of position
211.8%
1/16/2025
11.33K→35.33K
Total
Net shares
+24K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/16/2025 | A · Award | +24K | — | — | 211.8% | 11.33K | 35.33K |
| Total | +24K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported